Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Blood|May 5, 2018
Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock responseSanil Bhatia, Daniela Diedrich, Benedikt Frieg, et al.
The EMBO Journal|June 9, 2018
Lmo2 expression defines tumor cell identity during T-cell leukemogenesisIdoia García-Ramírez, Sanil Bhatia, Guillermo Rodríguez-Hernández, et al.
Human Molecular Genetics|September 19, 2013
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemiaBarbara Meissner, Thies Bartram, Cornelia Eckert, et al.
Nature Communications|December 6, 2019
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AIDGuillermo Rodríguez-Hernández, Friederike V Opitz, Pilar Delgado, et al.
Cancer Research|June 21, 2017
Infection Exposure Promotes <i>ETV6-RUNX1</i> Precursor B-cell Leukemia via Impaired H3K4 DemethylasesGuillermo Rodríguez-Hernández, Julia Hauer, Alberto Martín-Lorenzo, et al.
Blood Cancer Discovery|January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesRuth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.
Pageof 7